002099 海翔药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额16,958174,835240,537116,092102,361
投资活动产生之现金流量净额53,687(527,393)(128,215)(620,316)(509,007)
筹资活动产生之现金流量净额45,4093,46299,070(121,882)80,786
汇率变动对现金及现金等价物的影响(5,528)35,6941,10475,133(25,534)
现金及现金等价物净增加/(减少)110,527(313,403)212,496(550,973)(351,394)
期初现金及现金等价物余额936,1281,249,5311,037,0351,588,0081,939,402
期末现金及现金等价物余额1,046,655936,1281,249,5311,037,0351,588,008